George “G.B.” Pratt is the Founder and CEO of ModifyHealth. The company recently raised $2 million in Series A funding – right in the middle of the pandemic.
As a “food as medicine” company, ModifyHealth provides fresh, Low-FODMAP and Gluten-free meals to patients suffering from GI conditions. GI practices partner with the company to benefit from a dietary ancillary.
In this interview, you’ll learn more about ModifyHealth’s business model. A big question GB reflects on is whether ModifyHealth goes against the grain of today’s healthcare model.
Watch this thought-provoking interview in full (15min.47sec).
◘ GB’s background
◘ How ModifyHealth raised $2M in Series A funding in the middle of COVID-19
◘ “It was probably one of the first ‘zoom only’ fund-raising events”
◘ “We make it simple, effective and profitable for GI practices”
◘ The big picture that VCs are looking for
◘ Operating model of ModifyHealth
◘ Benefits patients get after using ModifyHealth
◘ “79% of patients report life-changing relief”
◘ The economic model of ModifyHealth
◘ “For most of our patients it’s cost-neutral”
◘ Benefit for GI practices referring to ModifyHealth
◘ “We’re a 100% aligned to where healthcare is heading”
_
By Praveen Suthrum, President & Co-Founder, NextServices.